ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Roche has licensed technology developed by collaborators Stuart Lindsay of Arizona State University’s Biodesign Institute and Colin Nuckolls of the Columbia University Nanoscience Center. Roche will use the DNA-reading technology to build on work its 454 Life Sciences business has been doing with IBM to develop a single-molecule nanopore DNA sequencer. The scientists’ method eliminates the need to use chemical reagents. Roche and IBM hope to create a system that can decode an individual’s genome for less than $1,000.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter